- IN₹69.36bn
- IN₹63.53bn
- IN₹19.43bn
- 95
- 24
- 46
- 58
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 3.02 | ||
Price to Tang. Book | 3.03 | ||
Price to Free Cashflow | 27.43 | ||
Price to Sales | 3.33 | ||
EV to EBITDA | 19.85 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 11.5% | ||
Return on Equity | 12.87% | ||
Operating Margin | 13.05% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | IN₹m | 13,441.91 | 13,332.03 | 15,279.19 | 17,837.5 | 19,429.44 | n/a | n/a | 12.24% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +34.79 | +35.09 | -28.21 | -8.94 | +57.97 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
FDC Limited is an India-based company, which is principally engaged in the business of pharmaceuticals. The Company manufactures and distributes its range of generics, formulations, and active pharmaceuticals at its manufacturing plants. It also manufactures oral rehydration salts (ORS) and specialized formulations. It has a range of functional foods and beverages. Its active pharmaceutical ingredients (APIs) include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen, Flurbiprofen Sodium, Miconazole Nitrate and Timolol Maleate, among others. It has its presence in various therapeutic segments, such as anti-infectives, gastrointestinal, ophthalmological, vitamins/ minerals/ dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Directors
- Mohan Chandavarkar CHM
- Varsharani Katre CCO
- Nandan Chandavarkar MDR
- Ameya Chandavarkar EDR
- Ashok Chandavarkar EDR
- Nomita Chandavarkar EDR
- Uday Gurkar NID
- Swati Mayekar NID
- Satish Ugrankar NID
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 23rd, 1940
- Public Since
- August 7th, 1997
- No. of Employees
- 6,659
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
National Stock Exchange of India
- Shares in Issue
- 162,810,084

- Address
- 142-148, S.V. Road, Jogeshwari (W), MUMBAI, 400053
- Web
- https://www.fdcindia.com/
- Phone
- +91 2226739100
- Contact
- Varsharani Katre
- Auditors
- BSR & Co. LLP
Upcoming Events for FDC
Q1 2026 F D C Ltd Earnings Release
F D C Ltd Annual Shareholders Meeting
Similar to FDC
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
As of Today at 20:35 UTC, shares in F D C are trading at IN₹425.60. This share price information is delayed by 15 minutes.
Shares in F D C last closed at IN₹425.60 and the price had moved by -6.86% over the past 365 days. In terms of relative price strength the F D C share price has underperformed the S&P BSE 100 Index by -12.26% over the past year.
The overall consensus recommendation for F D C is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe F D C dividend yield is 1.17% based on the trailing twelve month period.
Last year, F D C paid a total dividend of IN₹5.00, and it currently has a trailing dividend yield of 1.17%. We do not have any data on when F D C is to next pay dividends.
We do not have data on when F D C is to next pay dividends. The historic dividend yield on F D C shares is currently 1.17%.
To buy shares in F D C you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹425.60, shares in F D C had a market capitalisation of IN₹69.36bn.
Here are the trading details for F D C:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: FDC
Based on an overall assessment of its quality, value and momentum F D C is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in F D C is IN₹349.67. That is 17.84% below the last closing price of IN₹425.60.
Analysts covering F D C currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like F D C. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -15.84%.
As of the last closing price of IN₹425.60, shares in F D C were trading -12.86% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The F D C PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹425.60.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
F D C's management team is headed by:
- Mohan Chandavarkar - CHM
- Varsharani Katre - CCO
- Nandan Chandavarkar - MDR
- Ameya Chandavarkar - EDR
- Ashok Chandavarkar - EDR
- Nomita Chandavarkar - EDR
- Uday Gurkar - NID
- Swati Mayekar - NID
- Satish Ugrankar - NID